Ranbezolid
Alternative Names: Ranbezolid hydrochloride; RBx 7644Latest Information Update: 04 Nov 2017
At a glance
- Originator Ranbaxy Laboratories
- Developer Sun Pharmaceutical Industries
- Class Acetamides; Antibacterials; Furans; Oxazolidinones; Piperazines; Small molecules
- Mechanism of Action Bacterial protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Bacterial-infections in India
- 25 Mar 2015 Ranbaxy Laboratories has been acquired by Sun Pharmaceutical Industries
- 07 Jan 2009 Preclinical development is ongoing in India